Medicine recalls
|
| |
| Canada: Recall: Gamunex solution: may cause allergic / hypersensitivity type reaction |
| |
Health Canada announces that Grifols Canada Ltd. is recalling one lot of Gamunex solution (immunoglobulin (human) 10g/100mL) (lot number: B01J117643) from healthcare establishments because the affected lot may cause allergic / hypersensitivity type reaction.
The product is indicated in primary immune deficiency syndromes, secondary immune deficiency syndromes and neurological and/or autoimmune conditions.
Please refer to the following website in Health Canada for details:
http://recalls-rappels.canada.ca/en/alert-recall/gamunex-solution-may-cause-allergic-hypersensitivity-type-reaction
In Hong Kong, Gamunex-C Solution For Infusion 10% 5g/50ml (HK-63147) is a pharmaceutical product registered by Luen Cheong Hong Ltd (LCH). The product is a prescription-only medicine. As confirmed by LCH, the affected lot has not been imported into Hong Kong. Related news was previously issued by FDA, and was posted on the Drug Office website on 4 Mar 2022 and 11 Mar 2025.
Ends/Friday, Jun 20, 2025
Issued at HKT 17:30
|
| |
|
